207 related articles for article (PubMed ID: 35688908)
21. Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.
Stepan LP; Trueblood ES; Hale K; Babcook J; Borges L; Sutherland CL
J Histochem Cytochem; 2011 Jul; 59(7):701-10. PubMed ID: 21551320
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
[TBL] [Abstract][Full Text] [Related]
23. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Wang J; Zhang K; Grabowska D; Li A; Dong Y; Day R; Humphrey P; Lewis J; Kladney RD; Arbeit JM; Weber JD; Chung CH; Michel LS
Mol Cancer Res; 2011 Dec; 9(12):1686-95. PubMed ID: 21970857
[TBL] [Abstract][Full Text] [Related]
24. The oncogene Trop2 regulates fetal lung cell proliferation.
McDougall AR; Hooper SB; Zahra VA; Sozo F; Lo CY; Cole TJ; Doran T; Wallace MJ
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L478-89. PubMed ID: 21743029
[TBL] [Abstract][Full Text] [Related]
25. Trop2: Jack of All Trades, Master of None.
Lenárt S; Lenárt P; Šmarda J; Remšík J; Souček K; Beneš P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187148
[TBL] [Abstract][Full Text] [Related]
26. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release.
Kamble PR; Patkar SR; Breed AA; Pathak BR
Arch Biochem Biophys; 2021 Dec; 714():109084. PubMed ID: 34774484
[TBL] [Abstract][Full Text] [Related]
27. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.
Shen M; Liu S; Stoyanova T
Am J Clin Exp Urol; 2021; 9(1):73-87. PubMed ID: 33816696
[TBL] [Abstract][Full Text] [Related]
28. Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer.
Zhao W; Ding G; Wen J; Tang Q; Yong H; Zhu H; Zhang S; Qiu Z; Feng Z; Zhu J
Cancer Med; 2017 May; 6(5):994-1001. PubMed ID: 28256068
[TBL] [Abstract][Full Text] [Related]
29. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
30. Protein profile of basal prostate epithelial progenitor cells--stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo.
Höfner T; Klein C; Eisen C; Rigo-Watermeier T; Haferkamp A; Sprick MR
J Cell Mol Med; 2016 Apr; 20(4):721-30. PubMed ID: 26849468
[TBL] [Abstract][Full Text] [Related]
31. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
[TBL] [Abstract][Full Text] [Related]
32. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.
Cubas R; Zhang S; Li M; Chen C; Yao Q
Mol Cancer; 2010 Sep; 9():253. PubMed ID: 20858281
[TBL] [Abstract][Full Text] [Related]
33. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
Li Z; Jiang X; Zhang W
Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
35. Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.
Coates JT; Sun S; Leshchiner I; Thimmiah N; Martin EE; McLoughlin D; Danysh BP; Slowik K; Jacobs RA; Rhrissorrakrai K; Utro F; Levovitz C; Denault E; Walmsley CS; Kambadakone A; Stone JR; Isakoff SJ; Parida L; Juric D; Getz G; Bardia A; Ellisen LW
Cancer Discov; 2021 Oct; 11(10):2436-2445. PubMed ID: 34404686
[TBL] [Abstract][Full Text] [Related]
36. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.
Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J
Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786
[TBL] [Abstract][Full Text] [Related]
37. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy.
Nakatsukasa M; Kawasaki S; Yamasaki K; Fukuoka H; Matsuda A; Tsujikawa M; Tanioka H; Nagata-Takaoka M; Hamuro J; Kinoshita S
Am J Pathol; 2010 Sep; 177(3):1344-55. PubMed ID: 20651236
[TBL] [Abstract][Full Text] [Related]
38. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer.
Zhao P; Yu HZ; Cai JH
Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528
[TBL] [Abstract][Full Text] [Related]
39. EPCAM and TROP2 share a role in claudin stabilization and development of intestinal and extraintestinal epithelia in mice.
Szabo R; Ward JM; Artunc F; Bugge TH
Biol Open; 2022 Jul; 11(7):. PubMed ID: 35730316
[TBL] [Abstract][Full Text] [Related]
40. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
